Location History:
- Castro Valley, CA (US) (1995 - 2007)
- San Leandro, CA (US) (1994 - 2021)
Company Filing History:
Years Active: 1994-2021
Title: Teodorica L Bugawan: Innovator in Complement-Associated Conditions
Introduction
Teodorica L Bugawan is a notable inventor based in Castro Valley, CA (US). She has made significant contributions to the field of medicine, particularly in the treatment of degenerative diseases. With a total of 6 patents, her work focuses on innovative methods and compositions that address complex health issues.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Compositions and method for treating complement-associated conditions." This invention provides methods and compositions for treating various degenerative diseases, such as age-related macular degeneration (AMD), using a factor D inhibitor, which may include an anti-factor D antibody or an antigen-binding fragment thereof. Additionally, her work includes methods for selecting or identifying patients suitable for treatment with a factor D inhibitor, utilizing prognostic and predictive biomarkers. Another significant patent is "Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms," which also focuses on treating degenerative diseases with similar methodologies.
Career Highlights
Teodorica has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Genentech, Inc. Her experience in these organizations has allowed her to develop and refine her innovative approaches to medical treatments.
Collaborations
Throughout her career, Teodorica has collaborated with esteemed colleagues, including Henry A Erlich and Glenn T Horn. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Teodorica L Bugawan is a pioneering inventor whose work in treating complement-associated conditions has the potential to significantly impact the field of medicine. Her innovative patents and collaborations highlight her dedication to improving patient outcomes through scientific advancements.